Presentations & events

October 25, 2024 Presentation at Redeye’s Theme Event Neurology

September 17, 2024 Q&A with Kristina Torfgård, CEO, at “Investing in Life Science 2024”

September 16, 2024 Presentation by Kristina Torfgård, CEO, at “Investing in Life Science 2024”

September 13, 2024 CEO interview with Kristina Torfgård at Redeye

March 7, 2024 Fireside chat with Viktor Siewertz, CFO, at ABGSC

March 7, 2024 Erik Werner presents at Bayes@Lund 2024

March 6, 2024 Viktor Siewertz, CFO, presents at Life Science-dagen

March 6, 2024 IRLAB to present clinical and preclinical data at the AD/PD™ 2024: 18th International Conference on Alzheimer’s & Parkinson’s Diseases

February 7, 2024 Management presents in connection with the Year-end report 2023

November 23, 2023 Q&A session on Redeye Life Science Day

November 22, 2023 Gunnar Olsson, CEO, at ABGSC Investor Days

October 26, 2023 Viktor Siewertz, CFO, presented at BioStock Life Science Fall Summit 2023

October 25, 2023 Management presents Q3 report

October 11, 2023 Gunnar Olsson, CEO, at Redeye Neurology Theme Event

August 30, 2023 Fireside chat with Gunnar Olsson, CEO, at ABGSC

August 30, 2023 Q2 report and presentation

August 22, 2023 Management presents update on the mesdopetam project

June 20, 2023 CEO and CFO presented the company at the AGM 2023

June 1, 2023 Q&A session with Nicholas Waters, EVP, Head of R&D, and Viktor Siewertz, CFO, at Redeye Growth Day 2023

May 31, 2023 Nicholas Waters, EVP and Head of R&D, at ABGSC’s Life Science Summit 2023

May 10, 2023 Management presents in connection with Q1 2023

March 31, 2023 Symposia at AD/PD 2023: The management dilemma of Parkinson’s disease progression and emerging treatment approaches – supported by IRLAB

March 8, 2023 Nicholas Waters, EVP, Head of R&D presents at ABGSC Investor Day

February 24, 2023 Interview with Gunnar Olsson, CEO, and Nicholas Waters EVP Head of R&D

February 23, 2023 Management presents in connection with the Year-end report 2022

January 18, 2023 Presentation: Top-line results in Phase IIb trial of mesdopetam

November 17, 2022 Executive interview with Richard Godfrey, CEO, at Edison

November 16, 2022 Management presents in connection with the Q3 report publication

October 12, 2022 Richard Godfrey, CEO, presented at Redeye Theme: Neurology

September 29, 2022 Richard Godfrey, CEO, presented at ProHearings on Sep 29

September 14, 2022 Richard Godfrey, CEO, presents at ABGSC Investor Day

August 24, 2022 Management presents in connection with the Q2 report publication

June 13, 2022 Chair of the Board Gunnar Olsson in Trading Direkt Healthcare about the changes in management

June 13, 2022 Executive interview with Nicholas Waters at Edison

June 9, 2022 CFO Viktor Siewertz on dealmaking at BioStock Life Science Summit 2022

June 2, 2022 Q&A session with CEO Waters and CFO Siewertz at Redeye Growth Day 2022

June 2, 2022 Nicholas Waters, CEO, at Redeye Growth Day 2022

May 19, 2022 CEO presents at AGBSC Life Science Summit 2022

May 16, 2022 CEO on stage at Aktiedagen i Göteborg

March 22, 2022 IRLAB’s Capital Markets Day 2022

February 28, 2022 Interview Healthcare Direkt (Swedish)

February 23, 2022 Earnings call Q4, 2021

February 21, 2022 Edison Open House – Global healthcare

November 10, 2021 Earnings call Q3

August 25, 2021 Presention at ProHearings by Nicholas Waters, CEO (Swedish)

June 2, 2021 CEO Nicholas Waters, CEO, participated at Redeye Growth Day 2021

May 25, 2021 CEO Nicholas Waters presented at ABGSC Life Science Summit 2021

December 21, 2020 Interview with CEO and CFO regarding the December -20 share issue (Swedish)

December 3, 2020 Redeye Investor Forum online

November 26, 2020 Nicholas Waters, CEO, presents at Redeye Life Science Day 2020

October 16, 2020 Nicholas Waters, CEO, presents at ProHearings capital market day

October 15, 2020 Nicholas Waters, CEO, presents Redeye Neurology seminar

September 3, 2020 Nicholas Waters, CEO, presents at Pareto Securities’ Annual Healthcare Conference 2020

June 2, 2020 Nicholas Waters, CEO, presents at Redeye’s Growth Day 2020

May 26, 2020 Nicholas Waters, CEO, presents at ABGSC Life Science Summit 2020

May 18, 2020 Nicholas Waters, CEO, presents at Aktiedagen in Gothenburg

May 7, 2020 IRLAB’s CEO presentation for AGM 2020

March 4, 2020 Nicholas Waters, CEO, at Life Science-dagen 2020

February 19, 2020 Nicholas Waters, CEO, at Börsveckans Småbolagsdag 2020

November 19, 2019 Nicholas Waters, CEO, at Redeye Life Science Day 2019

July 18, 2019 CEO interviewed by Healthcare Direkt

June 10, 2019 CEO Nicholas Waters presented at Redeye Growth Day 2019

October 4, 2018 Nicholas Waters, CEO, presents at Redeye CNS Biotech Seminar 2018

September 5, 2018 Presentation by CEO Nicholas Waters at Börsveckans Småbolagsdag

June 7, 2018 CFO Viktor Siewertz presented at Redeye Growth day, June 4, 2018

March 15, 2018 Redeye interview with CEO Nicholas Waters

November 29, 2017 Video from Redeye Life Science Seminar, November 24, 2017

November 23, 2017 CEO Nicholas Waters presented at Avanzas börsdag Nov. 23

November 22, 2017 CEO Nicholas Waters to present at Redeye Life Science Seminar at 14.40 on Nov. 24

November 16, 2017 Video from presentation at Redeye November 16, 2017

October 10, 2017 Video from presentation at Redeye October 10, 2017

May 22, 2017 Video from Avanza Börsdag, Capital market day, May 24, 2017

April 24, 2017 IRLAB video presentation at Stockholm Corporate Finance Life Science & Healthcare seminarium 21-22 mars 2017